[E4] English Session 4
神経・筋疾患

[E-019] Safety and effectiveness of nusinersen in SMA type 2 and 3：Assessment of the real world data

Yuko Motohashi¹, Hiroyuki Yajima², Akihiko Ishiyama¹, Eri Takeshita¹, Yoko Kobayashi², Hirofumi Komaki¹, Masayuki Sasaki¹ (1.National Center of Neurology and Psychiatry, Department of Child Neurology, Tokyo, Japan, 2.National Center of Neurology and Psychiatry, Department of Rehabilitation, Tokyo, Japan)